Dumopol, Mary Jane .
HRN: 26-84-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
AMPICILLIN 1GM (VIAL)
03/18/2025
03/19/2025
IV
2 Grams
Q6
PROM; MSAF Thinly
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes